Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.

Odontogenic myxoma (OM) is a rare benign tumor originating from the odontogenic mesenchyme, characterized by locally aggressive behavior in the jaw bones. We present a case report of a 36-year-old ...